BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Akateh C, Black SM, Conteh L, Miller ED, Noonan A, Elliott E, Pawlik TM, Tsung A, Cloyd JM. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World J Gastroenterol 2019; 25(28): 3704-3721 [PMID: 31391767 DOI: 10.3748/wjg.v25.i28.3704]
URL: https://www.wjgnet.com/1007-9327/full/v25/i28/3704.htm
Number Citing Articles
1
Ahmed Montasser, Aurélie Beaufrère, François Cauchy, Mohamed Bouattour, Olivier Soubrane, Miguel Albuquerque, Valérie Paradis. Transarterial chemoembolisation enhances programmed death‐1 and programmed death‐ligand 1 expression in hepatocellular carcinomaHistopathology 2021; 79(1): 36 doi: 10.1111/his.14317
2
Qi Pan, Zigong Shao, Yijie Zhang, Hao Liu. MicroRNA-1178-3p suppresses the growth of hepatocellular carcinoma by regulating transducin (beta)-like 1 X-linked receptor 1Human Cell 2021; 34(5): 1466 doi: 10.1007/s13577-021-00565-5
3
Stefanie J. Hectors, Sara Lewis, Cecilia Besa, Michael J. King, Daniela Said, Juan Putra, Stephen Ward, Takaaki Higashi, Swan Thung, Shen Yao, Ilaria Laface, Myron Schwartz, Sacha Gnjatic, Miriam Merad, Yujin Hoshida, Bachir Taouli. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinomaEuropean Radiology 2020; 30(7): 3759 doi: 10.1007/s00330-020-06675-2
4
Hao Wu, Jinrui Zhang, Yi Bai, Sai Zhang, Zhixin Zhang, Wen Tong, Pinsheng Han, Bing Fu, Yamin Zhang, Zhongyang Shen. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinomaAging 2021;  doi: 10.18632/aging.203593
5
Kevin P. Labadie, Jonathan G. Sham. Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for EverybodyAnnals of Surgical Oncology 2020; 27(11): 4070 doi: 10.1245/s10434-020-08702-4
6
Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis, Alexandros Hardas, Athanasios Pseftogas, Kali Makedou, Athanasios Gargavanis, Thomas Goulopoulos, Stavros Iliadis, Vasileios Papadopoulos, Apostolos Papalois, George Mosialos, Theofilos Poutahidis, Dimitrios Giakoustidis. <p>HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice</p>OncoTargets and Therapy 2020; : 5575 doi: 10.2147/OTT.S250233
7
Zhenchang Wang, Yunjie Duan, Jinmei Zhang, Yanhang Lv, Shanshan Wu, Mingrong Cheng, Akshaya Srikanth Bhagavathula, Wafa Ali Aldhaleei, Cain Clark, Zongwei Huo. Preoperative antiviral therapy and microvascular invasion in hepatitis B virus-related hepatocellular carcinoma: A meta-analysisEuropean Journal of Pharmacology 2020; 883: 173382 doi: 10.1016/j.ejphar.2020.173382
8
Clifford Akateh, Aslam M Ejaz, Timothy Michael Pawlik, Jordan M Cloyd. Neoadjuvant treatment strategies for intrahepatic cholangiocarcinomaWorld Journal of Hepatology 2020; 12(10): 693-708 doi: 10.4254/wjh.v12.i10.693
9
Yao-chang Luo, Hai-lin Lu, Wen-ling Song, Fei-fei Xuan. Multidisciplinary treatment of advanced hepatocellular carcinoma with severe arterioportal shunt: a case reportJournal of International Medical Research 2021; 49(7): 030006052110248 doi: 10.1177/03000605211024840
10
Ying Liu, Yuzhu Wang, Xinkun Guo, Yifeng He, Jian Zhou, Qianzhou Lv, Xiaowu Huang, Xiaoyu Li. Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-AnalysisFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.709278
11
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi. Systemic adjuvant treatment in hepatocellular carcinoma: tempted to do something rather than nothingFuture Oncology 2020; 16(32): 2587 doi: 10.2217/fon-2020-0669
12
Bi Peng, Yuanliang Yan, Zhijie Xu. The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinomaPeerJ 2021; 9: e12123 doi: 10.7717/peerj.12123
13
Ahmed N. Elfadaly, Diamantis I. Tsilimigras, J. Madison Hyer, Alessandro Paro, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Impact of Tumor Burden Score on Conditional Survival after Curative-Intent Resection for Hepatocellular Carcinoma: A Multi-Institutional AnalysisWorld Journal of Surgery 2021; 45(11): 3438 doi: 10.1007/s00268-021-06265-3
14
Taicheng Lu, Liying Wei, Xiaoqing Huang, Yin Li, Guo Li, Qixiao Qin, Meishi Pan, Bingling Tang, Xin Pan, Mei Wei, Zhenzhen Nong, Fayan Meng, Xuehua Li. A potentially valuable nano graphene oxide/USPIO tumor diagnosis and treatment systemMaterials Science and Engineering: C 2021; 128: 112293 doi: 10.1016/j.msec.2021.112293
15
Hiroji Shinkawa, Shogo Tanaka, Shigekazu Takemura, Ryosuke Amano, Kenjiro Kimura, Masahiko Kinoshita, Kanae Takahashi, Shuichiro Matsuzaki, Shoji Kubo. Nomograms predicting extra- and early intrahepatic recurrence after hepatic resection of hepatocellular carcinomaSurgery 2021; 169(4): 922 doi: 10.1016/j.surg.2020.10.012
16
Min Wang, Shan Huang, Zefeng Chen, Zhiwei Han, Kezhi Li, Chuang Chen, Guobin Wu, Yinnong Zhao. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinomaBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07625-3
17
Chiun Hsu, Lorenza Rimassa, Hui-Chuan Sun, Arndt Vogel, Ahmed O. Kaseb. Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumabTherapeutic Advances in Medical Oncology 2021; 13: 175883592110311 doi: 10.1177/17588359211031141
18
Tomohiro Ishinuki, Shigenori Ota, Kohei Harada, Hiroomi Tatsumi, Keisuke Harada, Koji Miyanishi, Minoru Nagayama, Ichiro Takemasa, Toshio Ohyanagi, Thomas T Hui, Toru Mizuguchi. Health-related quality of life in patients that have undergone liver resection: A systematic review and meta-analysisWorld Journal of Meta-Analysis 2021; 9(1): 88-100 doi: 10.13105/wjma.v9.i1.88
19
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management StrategiesCancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
20
Bin Yu, Han Liang, Qifa Ye, Yanfeng Wang. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 ResectionJournal of Gastrointestinal Surgery 2021; 25(1): 112 doi: 10.1007/s11605-020-04554-1
21
S. V. Gautier, A. R. Monakhov, O. M. Tsirulnikova, S. I. Zubenko, E. V. Sitnikova, D. V. Umrik, K. A. Nosov, N. D. Kurtak. Outcomes of liver transplantation in hepatocellular carcinoma: a single-center experienceAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 67 doi: 10.16931/1995-5464.2020267-76
22
Zeyu Wang, Ningning Zhang, Jiayu Lv, Cuihua Ma, Jie Gu, Yawei Du, Yibo Qiu, Zhiguang Zhang, Man Li, Yong Jiang, Jianqiu Zhao, Huiqin Du, Zhiwei Zhang, Wei Lu, Yan Zhang, Luca Miele. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma PatientsBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4037639
23
Andreas Koulouris, Christos Tsagkaris, Vasiliki Spyrou, Eleni Pappa, Aikaterini Troullinou, Michail Nikolaou. Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment OptionsJournal of Hepatocellular Carcinoma 2021; : 387 doi: 10.2147/JHC.S300182
24
Francesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti, Rita Balsano, Federico Piacentini, Massimo Dominici, Fabio Gelsomino. The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A ReviewPharmaceuticals 2021; 14(1): 43 doi: 10.3390/ph14010043
25
Suchira Gallage, María García-Beccaria, Marta Szydlowska, Mohammad Rahbari, Raphael Mohr, Frank Tacke, Mathias Heikenwalder. The therapeutic landscape of hepatocellular carcinomaMed 2021; 2(5): 505 doi: 10.1016/j.medj.2021.03.002
26
Tao Wei, Xu-Feng Zhang, Feng Xue, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Silvia Silva, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Razvan Grigorie, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik. Multi-Institutional Development and External Validation of a Nomogram for Prediction of Extrahepatic Recurrence After Curative-Intent Resection for Hepatocellular CarcinomaAnnals of Surgical Oncology 2021; 28(12): 7624 doi: 10.1245/s10434-021-10142-7
27
H. Lang, S. Heinrich, F. Bartsch, F. Hüttl, J. Baumgart, J. Mittler. Chirurgische Therapie bei Lebertumoren – Leberresektion und -transplantationDer Internist 2020; 61(2): 147 doi: 10.1007/s00108-020-00754-8
28
Chien Peter Chen. Role of External Beam Radiotherapy in Hepatocellular CarcinomaClinics in Liver Disease 2020; 24(4): 701 doi: 10.1016/j.cld.2020.07.006
29
Alessandro Fancellu, Valeria Sanna, Fabrizio Scognamillo, Claudio F Feo, Gianpaolo Vidili, Giuseppe Nigri, Alberto Porcu. Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendationsWorld Journal of Clinical Cases 2021; 9(15): 3517-3530 doi: 10.12998/wjcc.v9.i15.3517
30
Clarisse Brossard, Manuel Vlach, Elise Vène, Catherine Ribault, Vincent Dorcet, Nicolas Noiret, Pascal Loyer, Nicolas Lepareur, Sandrine Cammas-Marion. Synthesis of Poly(Malic Acid) Derivatives End-Functionalized with Peptides and Preparation of Biocompatible Nanoparticles to Target Hepatoma CellsNanomaterials 2021; 11(4): 958 doi: 10.3390/nano11040958
31
Stepan M. Esagian, Christos D. Kakos, Emmanouil Giorgakis, Lyle Burdine, J. Camilo Barreto, Michail N. Mavros. Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsCancers 2021; 13(12): 2984 doi: 10.3390/cancers13122984
32
Qimeng Wang, Jin Huang, Huihua Zhang, Huan Liu, Min Yu. Identification and analysis of immune-related subtypes of hepatocellular carcinomaExperimental Biology and Medicine 2021; 246(6): 667 doi: 10.1177/1535370220970130
33
John R. Bergquist, Amy Y. Li, Christopher S. Javadi, Byrne Lee, Jeffrey A. Norton, George A. Poultsides, Monica M. Dua, Brendan C. Visser. Regional lymph node sampling in hepatoma resection: insight into prognosisHPB 2021; 23(9): 1360 doi: 10.1016/j.hpb.2021.01.006
34
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an updateClinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
35
Claudia A. M. Fulgenzi, Thomas Talbot, Sam M. Murray, Marianna Silletta, Bruno Vincenzi, Alessio Cortellini, David J. Pinato. Immunotherapy in Hepatocellular CarcinomaCurrent Treatment Options in Oncology 2021; 22(10) doi: 10.1007/s11864-021-00886-5
36
Congjian Shi, Hongqin Yang, Zhenghong Zhang. Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver DiseasesFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00139
37
Gi Hong Choi. Radiotherapy of Liver Cancer2021; : 209 doi: 10.1007/978-981-16-1815-4_15
38
Fuli Xin, Ming Wu, Zhixiong Cai, Xiaolong Zhang, Zuwu Wei, Xiaolong Liu, Jingfeng Liu. Tumor Microenvironment Triggered Cascade‐Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular CarcinomaAdvanced Healthcare Materials 2021; 10(10): 2002036 doi: 10.1002/adhm.202002036
39
Atsushi Oyama, Kazuhiro Nouso, Kenichi Yoshimura, Yuki Morimoto, Shinichiro Nakamura, Hideki Onishi, Akinobu Takaki, Shouta Iwadou, Kazuya Kariyama, Kenji Kuwaki, Kazuhisa Yabushita, Kosaku Sakaguchi, Jyunichi Toshimori, Haruhiko Kobashi, Akio Moriya, Masaharu Ando, Hiroyuki Okada. Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinomaHepatology Research 2021; 51(6): 694 doi: 10.1111/hepr.13633
40
Giovanni Galati, Antonio Fabio Massimo Vainieri, Claudia Angela Maria Fulgenzi, Stefano Di Donato, Marianna Silletta, Paolo Gallo, Angelo Onorato, Umberto Vespasiani-Gentilucci, Antonio Picardi. Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver CirrhosisCurrent Drug Metabolism 2020; 21(11): 866 doi: 10.2174/1389200221999200918141239